Anti-T cell receptor (TR, TR alpha_beta) [human] therapeutic antibody (Pre-made Maslimomab biosimilar, Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Maslimomab is a mouse monoclonal antibody[1] and an immunosuppressive drug.[2] It is an anti-human T-cell receptor alpha/beta chain.[1]